What is the description of an actinic keratosis (AK) papule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Actinic keratosis papules are typically described as rough, scaly papules on an erythematous base that develop in anatomic areas of high ultraviolet (UV) exposure. These lesions can have distinct presentations, including variants that range in appearance from atrophic to profoundly hypertrophic (or hyperkeratotic), and can also be pigmented or bowenoid in appearance 1. The amount of adherent scale can alter the appearance of AKs, with thicker amounts of epidermal hyperkeratosis usually associated with increased visibility and roughness.

  • Key characteristics of actinic keratosis papules include:
    • Rough, scaly texture
    • Erythematous base
    • Development in areas of high UV exposure
    • Variants in appearance, including atrophic, hypertrophic, pigmented, and bowenoid types
    • Presence of cutaneous horns in some cases According to the guidelines of care for the management of actinic keratosis, published in the Journal of the American Academy of Dermatology in 2021 1, these lesions can have a range of clinical presentations, and classification systems that assess both clinical and histologic characteristics or dermatoscopic findings are available.

From the FDA Drug Label

1.1 Actinic Keratosis Imiquimod Cream is indicated for the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. The studies enrolled subjects with 4 to 8 clinically typical, visible, discrete, nonhyperkeratotic, nonhypertrophic AK lesions within a 25 cm2 contiguous treatment area on either the face or scalp.

The actinic keratosis papule is described as clinically typical, visible, discrete, nonhyperkeratotic, nonhypertrophic lesions on the face or scalp in immunocompetent adults 2 2.

  • Key characteristics:
    • Clinically typical
    • Visible
    • Discrete
    • Nonhyperkeratotic
    • Nonhypertrophic Located on the face or scalp.

From the Research

Description of Actinic Keratosis Papule

Actinic keratosis (AK) is described as a skin disease caused by chronic sun damage, which in 75% of cases arises on chronically sun-exposed areas, such as the face, scalp, neck, hands, and forearms 3. It is characterized by intraepithelial keratinocyte dysplasia and molecular alterations shared with normal chronically sun-damaged skin and squamous cell carcinoma (SCC) 4.

Characteristics of Actinic Keratosis

The key characteristics of actinic keratosis include:

  • Premalignant skin lesions with the risk of converting into squamous cell carcinoma 5
  • Potential to undergo spontaneous regression, stable existence, or malignant transformation to cutaneous SCC 4
  • Progression rates to SCC ranging from 0% to 0.5% per lesion-year and AK spontaneous regression of 15-63% 4

Clinical Presentation

Actinic keratosis papules are often associated with alteration of the surrounding skin (field) where subclinical lesions might be present 6. The clinical presentation of AK can vary, but it is commonly described as a skin lesion that can be felt and seen on sun-exposed areas.

Treatment Options

There are various treatment options available for actinic keratosis, including:

  • Lesion-directed therapies: cryotherapy, laser therapy, surgery, and curettage 3
  • Field-directed therapies: 5-fluorouracil, diclofenac 3% gel, chemical peeling, imiquimod, and photodynamic therapy (PDT) 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current therapies for actinic keratosis.

International journal of dermatology, 2020

Research

Contemporary management of actinic keratosis.

The Journal of dermatological treatment, 2021

Research

[Diagnosis and treatment of actinic keratosis].

Duodecim; laaketieteellinen aikakauskirja, 2015

Research

Interventions for actinic keratoses.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.